🍽️ enterococcus durans (probiotics)

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of enterococcus durans (probiotics) On Probiotics

Rank Probiotic Impact

Bacteria Impacted by enterococcus durans (probiotics)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Oscillospiraceae family Increases 👪 Source Study
Ruminococcaceae family Increases 📓 Source Study
Acutalibacter genus Increases 👶 Source Study
Drancourtella genus Increases 👶 Source Study
Harryflintia genus Increases 👶 Source Study
Massilimalia genus Increases 👶 Source Study
Neobittarella genus Increases 👶 Source Study
Provencibacterium genus Increases 👶 Source Study
Acetanaerobacterium genus Increases 👶 Source Study
Acetivibrio genus Increases 👶 Source Study
Agathobaculum genus Increases 👶 Source Study
Anaerofilum genus Increases 👶 Source Study
Anaeromassilibacillus genus Increases 👶 Source Study
Anaerotruncus genus Increases 👶 Source Study
Angelakisella genus Increases 👶 Source Study
Bittarella (ex Durand et al. 2017) genus Increases 👶 Source Study
Candidatus Soleaferrea genus Increases 👶 Source Study
Caproiciproducens genus Increases 👶 Source Study
Ethanoligenens genus Increases 👶 Source Study
Flavonifractor genus Increases 👶 Source Study
Fournierella genus Increases 👶 Source Study
Gemmiger genus Increases 👶 Source Study BMI, fat percent,blood pressure
Gorbachella genus Increases 👶 Source Study
Hydrogenoanaerobacterium genus Increases 👶 Source Study
Negativibacillus genus Increases 👶 Source Study
Neglectibacter genus Increases 👶 Source Study
Oscillospira genus Increases 👶 Source Study
Papillibacter genus Increases 👶 Source Study
Phocea genus Increases 👶 Source Study
Pseudoflavonifractor genus Increases 👶 Source Study
Ruminococcus genus Increases 👶 Source Study
Ruthenibacterium genus Increases 👶 Source Study
Sporobacter genus Increases 👶 Source Study
Subdoligranulum genus Increases 👶 Source Study
Faecalibacterium genus Increases 📓 Source Study
environmental samples no rank Increases 👶 Source Study
unclassified Faecalibacterium no rank Increases 👶 Source Study
Oscillospiraceae incertae sedis no rank Increases 👶 Source Study
environmental samples norank Increases 👶 Source Study
Eubacteriales order Increases 👪 Source Study
Pseudoflavonifractor capillosus species Increases ⚗️ Source Study
Faecalibacterium duncaniae species Increases 👶 Source Study
Faecalibacterium hominis (ex Afrizal et al. 2022) species Increases 👶 Source Study
Faecalibacterium longum species Increases 👶 Source Study
Faecalibacterium prausnitzii species Increases 👶 Source Study
Faecalibacterium sp. An122 species Increases 👶 Source Study
Faecalibacterium sp. OF04-11AC species Increases 👶 Source Study
Faecalibacterium sp. OM04-11BH species Increases 👶 Source Study
Faecalibacterium sp. species Increases 👶 Source Study
Faecalibacterium sp. canine oral taxon 147 species Increases 👶 Source Study
Faecalibacterium sp. DJF_VR20 species Increases 👶 Source Study

Impact of enterococcus durans (probiotics) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.2 0.2
Acne 0.8 0.2 3
ADHD 1.9 0.4 3.75
Age-Related Macular Degeneration and Glaucoma 0.3 0.3
Allergic Rhinitis (Hay Fever) 0.6 -0.6
Allergies 0.5 1.2 -1.4
Allergy to milk products 1.4 -1.4
Alzheimer's disease 2 1.6 0.25
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.2 1.3 -5.5
Ankylosing spondylitis 0.2 0.6 -2
Anorexia Nervosa 1.6 0.8 1
Asthma 1.4 0.2 6
Atherosclerosis 0.6 0.8 -0.33
Atrial fibrillation 0.6 0.2 2
Autism 2.1 2.2 -0.05
benign prostatic hyperplasia 0.3 0.3
Bipolar Disorder 1.7 1.9 -0.12
Brain Trauma 0.8 0.2 3
Breast Cancer 0.2 0.2
Carcinoma 0.7 0.5 0.4
Celiac Disease 2.2 2.2
Cerebral Palsy 0.8 0.8
Chronic Fatigue Syndrome 1 0.6 0.67
Chronic Kidney Disease 0.8 0.2 3
Chronic Obstructive Pulmonary Disease (COPD) 0.3 0.2 0.5
Chronic Urticaria (Hives) 0.8 0.8
Coagulation / Micro clot triggering bacteria 0.5 0.5
Colorectal Cancer 0.6 0.5 0.2
Constipation 0.6 0.3 1
Coronary artery disease 0.2 0.5 -1.5
COVID-19 1.9 1.1 0.73
Crohn's Disease 2.8 2 0.4
cystic fibrosis 0.9 0.9
deep vein thrombosis 0.5 0.5
Depression 2.2 1.8 0.22
Eczema 0.8 -0.8
Endometriosis 0.4 1 -1.5
Eosinophilic Esophagitis 0.2 0.2
Epilepsy 0.8 1.6 -1
erectile dysfunction 0.3 0.3
Fibromyalgia 0.8 1 -0.25
Functional constipation / chronic idiopathic constipation 0.6 2 -2.33
gallstone disease (gsd) 0.6 0.7 -0.17
Glioblastoma 0.9 0.9
Gout 0.6 0.6
Graves' disease 0.2 0.2
Halitosis 0.2 -0.2
Hashimoto's thyroiditis 0.6 0.2 2
hypercholesterolemia (High Cholesterol) 0.6 0.2 2
hyperglycemia 0.2 0.6 -2
hypersomnia 0.2 0.2 0
hypertension (High Blood Pressure 1.5 0.8 0.88
Hypothyroidism 1.1 0.5 1.2
IgA nephropathy (IgAN) 0.2 0.6 -2
Inflammatory Bowel Disease 1.5 0.8 0.88
Insomnia 0.9 0.9
Intelligence 0.4 0.5 -0.25
Intracranial aneurysms 0.6 1.5 -1.5
Irritable Bowel Syndrome 1.3 1.3 0
Liver Cirrhosis 1.1 1.1 0
Long COVID 2.6 3.1 -0.19
Low bone mineral density 0.5 0.5
Lung Cancer 0.9 0.2 3.5
ME/CFS with IBS 0.8 0.8
ME/CFS without IBS 0.4 -0.4
Metabolic Syndrome 2.2 2.5 -0.14
Mood Disorders 2.2 3 -0.36
multiple chemical sensitivity [MCS] 0.2 0.2
Multiple Sclerosis 1.9 1 0.9
Multiple system atrophy (MSA) 0.2 0.2
Neuropathy (all types) 0.2 -0.2
neuropsychiatric disorders (PANDAS, PANS) 1.2 1.2
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 1.9 0.6 2.17
Obesity 3.3 1.8 0.83
obsessive-compulsive disorder 1.4 0.8 0.75
Osteoarthritis 1.3 1.3
Osteoporosis 0.8 0.8 0
pancreatic cancer 0.3 -0.3
Parkinson's Disease 1.8 1.3 0.38
Polycystic ovary syndrome 0.6 0.4 0.5
primary biliary cholangitis 0.3 0.3
Psoriasis 0.8 -0.8
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.8 1.8 -1.25
Rosacea 0.2 -0.2
Schizophrenia 0.8 1.5 -0.88
scoliosis 0.2 0.3 -0.5
Sjögren syndrome 1.6 0.8 1
Sleep Apnea 0.6 0.8 -0.33
Small Intestinal Bacterial Overgrowth (SIBO) 0.3 -0.3
Stress / posttraumatic stress disorder 1.6 1.6
Systemic Lupus Erythematosus 1.9 0.2 8.5
Tic Disorder 1.1 -1.1
Tourette syndrome 0.3 0.3
Type 1 Diabetes 1.2 0.2 5
Type 2 Diabetes 1.9 2.5 -0.32
Ulcerative colitis 1.8 1.3 0.38
Unhealthy Ageing 0.8 0.8

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)